DeVita, Seffrin Present Cancer Czar PlanTo Feinstein, Without Committee Sign-Off
Varmus, Branscomb Win Public Service Award From NSF; NCI Clarifies Plans For Large R01s
President’s Cancer Panel: NCI’s Approach “Paying Off,” Thompson Tells Cancer Panel
NCI Clarifies Plan For Review Of Epidemiologic Research
Clinical Trials: For ER+ Breast Cancer, Post-Tamoxifen, NSABP Testing Aromasin In Large Trial
Oncology Management: US Oncology To Conduct Up To 5 Studies Of PG-TXL In Colorectal, Lung Cancers
Deals & Collaborations: UAB To Evaluate Firm’s Prostate Cancer Treatment
Emerging Technologies: Company To Expand Program Studying Polymer Platinates
Trending Stories
- What will Trump’s return to the White House mean for oncology?
“Our work just got a lot more difficult.” - Trump 2016: A look back at the 45th president’s impact on oncology
- A study measures the long-term downside of prostate cancer screening
A paper in JAMA Oncology focuses on the harms of overscreening, overdiagnosis, and overtreatment - At an uncertain time for cancer research and public health, Wayne Frederick steps in as interim CEO at ACS
- GRAIL’s woes raise questions about the prospects of MCDs and standards for their evaluation
- Long-term risks from prostate cancer treatment detailed in new report